Cross-immunizing antigen vaccine and method for preparation thereof
AssigneesGreen BioMed, Inc., Kirin Holdings Kabushiki Kaisha
InventorKenji SEKIKAWA
Life of this patent
Estimating the term…
Loading patent…
AssigneesGreen BioMed, Inc., Kirin Holdings Kabushiki Kaisha
InventorKenji SEKIKAWA
Estimating the term…
The present invention provides a fusion polypeptide that induces a humoral immune response and a cellular immune response to a virus, containing antigens or fragments thereof of the following (a) and (b), and having an oligomerization activity: (a) an antigen of the virus or a fragment thereof containing a B cell epitope conserved among subtypes of the virus; and (b) an antigen of the virus or a fragment thereof containing a T cell epitope conserved among subtypes of the virus (wherein the antigen(s) or the fragment(s) thereof of (a) and/or (b) have an oligomerization activity, or the fusion polypeptide further contains (c) a polypeptide having an oligomerization activity in addition to the antigens or the fragments thereof (a) and (b)).
A fusion polypeptide that induces a humoral immune response and a cellular immune response to a virus, comprising antigens or fragments thereof of the following (a) and (b), and having an oligomerization activity:
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.